For instance, IL6/IL6ST signaling plays a key role in the progression of RA, and some IL6 receptor antagonists have been proved to be effective in altering leukocyte trafficking and reducing the severity of RA [29]. This evidence concerns the gene IL6ST and rheumatoid arthritis.